Table 2.
Overall Use of Therapies for Acute Myocardial Infarction According to the Level of Cardiologist Involvement*
| Generalist Attending vs Cardiologist Attending | Collaborative Care vs Cardiologist Attending | |||
|---|---|---|---|---|
| Therapy | Odds Ratio (95% Cl) | Adjusted Odds Ratio†(95% Cl) | Odds Ratio (95% Cl) | Adjusted Odds Ratio†(95% Cl) |
| Aspirin | 0.28 (0.24 to 0.33) | 0.58 (0.42 to 0.80) | 0.71 (0.61 to 0.82) | 1.10 (0.90 to 1.34) |
| β Blockers | 0.29 (0.25 to 0.35) | 0.93 (0.66 to 1.31) | 0.76 (0.66 to 0.87) | 0.93 (0.84 to 1.40) |
| Thrombolytic | 0.23 (0.19 to 0.27) | 0.18 (0.13 to 0.25) | 0.41 (0.35 to 0.47) | 0.45 (0.38 to 0.53) |
| CCBs | 0.71 (0.57 to 0.88) | 0.83 (0.57 to 1.21) | 0.86 (0.72 to 1.02) | 0.88 (0.71 to 1.09) |
| Lidocaine | 0.79 (0.66 to 0.94) | 0.78 (0.55 to 1.09) | 0.76 (0.66 to 0.88) | 0.86 (0.72 to 1.03) |
*From 5138 patients hospitalized with acute myocardial infarction (AMI). Cardiologist attendings cared for 1164 patients, and were consulted for 2727 patients (collaborative care); generalist attendings cared for 1247 patients. CCBs indicates calcium channel blockers, CI, confidence interval.
†
Separate multivariate models for each therapy with cardiologist attendings as the reference group; adjusted for all significant variables presented in Table 1, using multiple logistic regression and generalized estimating equations (see Methods).